AMRI provides you with all of the tools to successfully complete your PALS recertification. Our course is fast and flexible. Renew your PALS Certification today!
When all other solutions fail, obese adults with a body mass index (BMI) between 35 and 45 now have a new surgical option to help them get their weight under control. The FDA has granted approval for the Maestro Rechargeable System, a pacemaker-like device that controls hunger by targeting nerve activity between the brain and the stomach. The device is implanted into the abdomen by a surgeon during an outpatient procedure. It is the first surgical weight loss device to be approved by the FDA in eight years, making it one of only three FDA-approved weight loss devices on the market.
In an 18-month trial, patients who had the device implanted experienced 8.5 percent more weight loss than those who did not. While this finding fell short of the desired 10 percent, the FDA said it believes the benefits of this new device outweigh the risks. According to Outpatient Surgery Magazine, half of the patients in the trial who used the device lost at least 20 percent of their body weight, while almost 40 percent lost more than 25 percent.
Read the entire article to learn more.
